Screening and approval program for retail sale of products containing certain substances; establish.
Summary
House Bill 873 would create a new screening and approval program within the Mississippi State Department of Health for over-the-counter products containing substances that could be recreationally used or abused. The bill defines that category broadly to include substances used without physician supervision for enjoyment, relaxation, perceived health benefits, social reasons, or other illegitimate purposes, and substances that are unpredictable, potentially harmful, or capable of causing dependence and other health or social problems. The bill specifically references products such as bath salts, kratom, and tianeptine as examples of the kinds of substances the program is intended to address.
Under the bill, the State Health Officer, or a designee, would have authority to approve or deny the retail sale and over-the-counter availability of such products. The decision could be based on anecdotal, scientific, or other relevant evidence. Manufacturers or distributors whose products are denied would have a right to appeal to the State Board of Health within 30 days, and the department would be required to adopt rules and regulations to carry out the program. The act would take effect July 1, 2025.
Impact
HB873 would add a new layer of state oversight over the retail sale of certain consumer products containing potentially abusable substances, shifting approval authority to the Mississippi State Department of Health and State Health Officer. It would not directly ban all such products, but it would allow the state to restrict over-the-counter availability on a product-by-product basis and create an administrative appeal process for affected manufacturers and distributors. The bill also preserves local authority by stating that municipal and county ordinances or regulations limiting or prohibiting these products are not superseded by the state program.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the overall sentiment appears to be precautionary and public-health oriented. The bill is framed as a consumer safety measure aimed at reducing access to products associated with misuse or abuse, particularly kratom, bath salts, and tianeptine. No contrary viewpoints are documented in the provided context, but the structure of the bill suggests it anticipates industry concern by including an appeal process for denied products.
Contention
The main points of potential contention are the breadth of the definition of substances with the potential to be recreationally used or abused, the discretion given to the State Health Officer to rely on anecdotal as well as scientific evidence, and the impact on manufacturers, distributors, and retailers of products that may be lawful but controversial. Another likely issue is the balance between statewide regulation and local control, although the bill expressly preserves municipal and county ordinances. The inclusion of kratom and tianeptine may also draw debate because those products are commonly discussed in the context of supplement, wellness, and harm-reduction markets as well as abuse concerns.